|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 10,78 EUR | +0,78% |
|
+0,33% | +17,89% |
| 04/12 | Grifols Bereikt Zelfvoorzienendheid in Plasma-afgeleide Geneesmiddelen in Egypte | RE |
| 03/12 | Europese aandelen als Amerikaanse depositary receipts hoger op woensdag | MT |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Omzet (N-1) | Nettomarge (N-1) | Ebit-marge (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | |
|---|---|---|---|---|---|---|---|
 | 7,47 mld. | 2,18% | 18,81% | 2,79% | 0,74% | 5.16x | |
| 14,2 mld. | 31,07% | 36,7% | 19,23% | 15,02% | -1.11x | |
| 15,56 mld. | 19,3% | 28,72% | 16,36% | 7,75% | 1.74x | |
| 6,37 mld. | 17,31% | 13,59% | 11,21% | 6,48% | 0.99x | |
| 3,08 mld. | 23,82% | 29,03% | 10,45% | 6,49% | 0.1x | |
| 9,68 mld. | 16,87% | 31,16% | 10,36% | 5,95% | 1.06x | |
| 4,24 mld. | 0,77% | 9,76% | 5,27% | 3,72% | -4.29x | |
| 1,29 mld. | -1% | -8,02% | -0,74% | -0,45% | -11.4x | |
| 69,63 mln. | 59,01% | 24,7% | 28,77% | 18,72% | -6.16x | |
| 681 mln. | -10,97% | -17,14% | -8,58% | -7,13% | 8.63x | |
| 222 mln. | -241,44% | -267,22% | 35,11% | -73,11% | -1.77x | |
| 2,35 mld. | 14,93% | 22,42% | 10,9% | 5,41% | 1.59x | |
| 3,24 mld. | -110,04% | -121,91% | -28,77% | -21,87% | 1.87x | |
| 10,9 mln. | -2.957,71% | -3.477,43% | -33,47% | - | 3.99x | |
| 2,85 mld. | 14,96% | 16,97% | 8,05% | 6,17% | -0.93x | |
| 1,25 mld. | 22,95% | 28,06% | 14,19% | 8,74% | 0.28x | |
| 308 mln. | 4,73% | 4,18% | 0,85% | - | -5.29x | |
| 386 mln. | -74,47% | -72,74% | -231,63% | -49,66% | 0.49x | |
| 291 mln. | 30,69% | 22,61% | 10,34% | - | -8.45x | |
| Gemiddelde | 3,87 mld. | -165,11% | -193,57% | -6,28% | -4,19% | -0,71x | |
| Gewogen gemiddelde per kap. | 6,99 mld. | -68,13% | -79,87% | 6,44% | 3,08% | -0,42x |
- Beurs
- Aandelen
- Koers GRF
- Sector Grifols, S.A.
- Financiële vergelijkingen
Kies jouw editie
Alle financiële informatie op nationaal niveau
